Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about the unregistered sales of equity securities.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The disclosures provided in Item 1.01 are also included in this section as mandated by Form 8-K requirements.
For further insights into DNTH stock, check out TipRanks’ Stock Analysis page.
